Background and Aim: Development of overt hepatic encephalopathy (HE) is associated with poor prognosis in patients with cirrhosis. Lactulose is used for the treatment of HE. There is no study on ...

Improved disease staging tool for hepatic ... recurrence of overt HE. One key disclosure at EASL is the development of a patient-staging protocol – mHEST (modified Hepatic Encephalopathy Staging ...

but recommend caution as treatment with histamine H1 blockers carries a risk for the development of overt hepatic encephalopathy.

Furthermore, only patients who consumed yoghurt significantly improved their psychometric test results, and only patients in the no treatment arm (25%) developed overt hepatic encephalopathy.